Dose per serving from products
85 products in our catalogue print how much Bacopa Monnieri a serving holds.
Most common: 50 mg to 100 mg and 250 mg to 500 mg, 26% of 85 products each.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 3 |
| 25 mg to 50 mg | 16 |
| 50 mg to 100 mg | 22 |
| 100 mg to 250 mg | 15 |
| 250 mg to 500 mg | 22 |
| 500 mg to 1 g | 4 |
| over 1 g | 3 |
Dose per serving from research
8 study groups in 7 studies say how much Bacopa Monnieri participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mg to 500 mg, 63% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg or less | 1 |
| 100 mg to 250 mg | 0 |
| 250 mg to 500 mg | 5 |
| 500 mg to 1 g | 2 |
Benefit Evidence
Research sources
Memory (7)
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial
PubMed ID: 38538390
MCI trial showed domain‑specific improvements (attention and verbal fluency) and overall cognitive score at 2 months.
- Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled study
PubMed ID: 38512715
Polyphenolic formula including Bacopa improved delayed recall vs placebo.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Significant improvement in AVLT delayed word recall versus placebo in older adults.
- Chronic effects of Brahmi (Bacopa monnieri) on human memory
PubMed ID: 12093601
Explicit finding: reduced forgetting of new information (better delayed recall) in middle‑aged adults.
- Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial
PubMed ID: 20590480
Clear improvements in AVLT delayed recall and learning trials indicate enhanced retention of verbal information.
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Immediate word recall and attention span improved in a multi‑herb trial, consistent with retention gains.
- Characterization of Metabolites in Plasma, Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach
PubMed ID: 34063409
Metabolomics trial associated Bacopa product with improved memory speed in older volunteers.
Focus & concentration (5)
- Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial
PubMed ID: 35041248
Reduced cognitive errors and improved executive function in children indicate better focused performance.
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Multi‑herb trial improved attention span and other cognitive measures in dementia patients.
- Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial
PubMed ID: 20590480
Enhanced learning/AVLT performance implies improved attentional resources during tasks.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Improved Stroop/selective attention performance demonstrates better focused attention.
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial
PubMed ID: 38538390
MCI trial showed attention improvements at 1–2 months, indicating better focus in impaired older adults.
Healthy aging (5)
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
12‑month multi‑herb trial in dementia patients and healthy elderly reported cognitive and biomarker improvements.
- Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial
PubMed ID: 20590480
Healthy older adults showed improved verbal learning and retention over 12 weeks—relevant to aging cognition.
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial
PubMed ID: 38538390
MCI trial reported attention and verbal fluency improvements over 2 months in an older/at‑risk population.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Older adults had improved delayed recall and attention plus mood benefits over 12 weeks.
- Characterization of Metabolites in Plasma, Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach
PubMed ID: 34063409
Metabolomic and memory speed changes in older volunteers indicate mechanistic support for aging cognition.
Mood balance (5)
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Cognitive and biomarker improvements in dementia and healthy elderly as part of a multi‑herb formulation indicate potential wellness benefits.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Reduced depression/anxiety scores and decreased heart rate in older adults indicate improved mood/arousal.
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 41091332
Participants reported less stress and less fatigue despite null objective cognitive outcomes—indicative of improved subjective mental wellness.
- Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled study
PubMed ID: 38512715
Positive affect improved in a polyphenolic formula that included Bacopa.
- Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation
PubMed ID: 32236999
Augmentation of citalopram with Bacopa produced greater improvements in anhedonia and depressive symptoms.
Stress & Anxiety (5)
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Reduced inflammatory markers in the multi‑herb trial can relate to lower physiological stress.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Combined reductions in state/trait anxiety scores in older adults provide direct anxiety evidence.
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 41091332
12‑week RCT reported statistically significant reductions in self‑reported stress reactivity and less task fatigue.
- Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation
PubMed ID: 32236999
Augmentation study reduced depressive symptoms/anhedonia; anxiety effects plausible though secondary.
- Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial
PubMed ID: 29188854
Small pilot with multi‑ingredient nutraceutical reduced perceived stress (PSQ Index).
Learning (4)
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Stroop and attention improvements imply faster processing in selective tasks.
- Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial
PubMed ID: 20590480
RCT showed significant improvements in AVLT learning trials (acquisition), indicating faster/greater learning.
- Characterization of Metabolites in Plasma, Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach
PubMed ID: 34063409
Metabolomics study associated Bacopa product with improved memory speed in older volunteers.
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial
PubMed ID: 38538390
Attention improvements in MCI could reflect faster cognitive processing in targeted domains.
Mental clarity (4)
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Improved selective attention / Stroop performance and mood decreases support clearer cognition.
- Characterization of Metabolites in Plasma, Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach
PubMed ID: 34063409
Metabolomic changes associated with improved memory speed, implying mechanistic support for clarity.
- Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled study
PubMed ID: 38512715
Polyphenolic product including Bacopa improved delayed recall and positive affect, linked to clearer cognition.
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 41091332
Participants reported reduced stress and lower fatigue after tasks, which can subjectively improve clarity despite null objective cognition.
Endurance (2)
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 41091332
Reduced fatigue after a cognitively demanding task indicates improved task endurance.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
PubMed ID: 18611150
Attention and Stroop gains imply improved sustained cognitive performance over time.
Antioxidant (1)
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Multi‑herb trial including Bacopa showed reduced TBARS and increased GSH, direct oxidative‑stress biomarker improvements.
Brain health (1)
- Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product
PubMed ID: 25316430
Dementia cohort showed cognitive improvements plus reduced oxidative stress/inflammatory markers—signals of neuroprotection (multi‑herb formula including Bacopa).
Sleep quality (1)
- Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial
PubMed ID: 35041248
In boys 6–14, Bacopa improved sleep routine measures in a 14‑week RCT.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Bacopa Monnieri
Search all285 products whose verified label declares Bacopa Monnieri — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.